IP Library Granted Patent US 8,299,235
Granted Patent B2
US 8,299,235 · App. 11/013,315 · Granted Oct 30, 2012

RNA molecules and vectors for gene silencing

Assignee: Plant Bioscience Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,299,235
App. No.
11/013,315
Granted
Oct 30, 2012
Kind
B2
Abstract

The invention is directed to compositions for gene silencing by providing short RNA molecules to cells.

Claims (23)

1. A composition for introduction into a cell to effect gene silencing, consisting essentially of isolated short antisense RNA molecules (SARMs) and isolated short sense RNA molecules (SSRMs), collectively short RNA molecules (SRMs),

wherein the SSRMs and the SARMs consist of 21-30 nucleotides;

wherein said SARMS are complementary to, and can base pair with, a target RNA, which target RNA is transcribed from a gene that is silenced when said SRMs are present in a cell containing said gene, and said SSRMs correspond to the target RNA; and

wherein said gene is endogenous to an organism selected from the group consisting of a plant, a mammal, an avian organism, a reptile, an insect, and a protozoan, or

said target RNA is generated by a pathogen.

2. The composition of claim 1 wherein said SRMs are unmodified.

3. The composition of claim 1 wherein each SSRM and each SARM consists of 25 nucleotides.

4. The composition of claim 1 wherein each SSRM and each SARM consists of 26 nucleotides.

5. The composition of claim 1 wherein each SSRM and each SARM consists of 27 nucleotides.

6. The composition of claim 1 wherein each SSRM and each SARM consists of 28 nucleotides.

7. The composition of claim 1 wherein each SSRM and each SARM consists of 29 nucleotides.

8. The composition of claim 1 wherein each SSRM and each SARM consists of 30 nucleotides.

9. A composition for introduction into a cell to effect gene silencing, which composition comprises at least one vector which, when introduced into a cell, produces short antisense RNA molecules (SARMs) and short sense RNA molecules (SSRMs), said SARMs and SSRMs designated, collectively, short RNA molecules (SRMs),

wherein the SSRMs and SARMs consist of 20-30 nucleotides;

wherein said SARMs are complementary to, and can base pair with, a target RNA, which target RNA is transcribed from a gene that is silenced when said SRMs are present in a cell containing said gene, and said SSRMs correspond to the target RNA;

wherein said gene is endogenous to an organism selected from the group consisting of a plant, a mammal, an avian organism, a reptile, an insect, and a protozoan, or

said target RNA is generated by a pathogen.

10. The composition of claim 9 wherein each SSRM and each SARM consists of 25 nucleotides.

11. The composition of claim 9 wherein each SSRM and each SARM consists of 26 nucleotides.

12. The composition of claim 9 wherein each SSRM and each SARM consists of 27 nucleotides.

13. The composition of claim 9 wherein each SSRM and each SARM consists of 28 nucleotides.

14. The composition of claim 9 wherein each SSRM and each SARM consists of 29 nucleotides.

15. The composition of claim 9 wherein each SSRM and each SARM consists of 30 nucleotides.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2008
From: BAULCOMBE, DAVID CHARLES; HAMILTON, ANDREW JOHN
To: PLANT BIOSCIENCE LIMITED
Reel/Frame 022046/0728 →
Priority Claims (1)
GB 9925459.1 · Oct 27, 1999 · national
Continuity (3)
Division 10805804 · Mar 22, 2004
Division 09491549 · Jan 26, 2000
Related Publication 20050102709A1 · May 12, 2005